Manufacturer record
Super Formulations Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
18 batches manufactured by Super Formulations Pvt. Ltd (Madhya Pradesh) were declared Not of Standard Quality between July 2021 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: GAMT2, Amitripyline Tablets IP 25mg (exp May 2027). Drug Testing Laboratory, Madurai-19 (state lab) found it not of standard quality: content- Amitriptyline Hydrochloride. Listed in the September 2026 alert.
Records by type
18 records linked to Super Formulations Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Amitripyline Tablets IP 25mg | Batch GAMT2Mfg Jun 2025 · Exp May 2027 | content- Amitriptyline HydrochlorideOther | Drug Testing Laboratory, Madurai-19State lab | Sep 2026 |
| Oral Rehydration Salts IP | Batch 4092Mfg Jun 2026 · Exp May 2028 | Average Net WeightWeight | SDTL, PunjabState lab | Aug 2026 |
| Oral Rehydration Salts IP | Batch 4063Mfg May 2026 · Exp Apr 2028 | Net WeightWeight | Govt Analyst PunjabState lab | Jul 2026 |
| Oral Rehydration Salts IP | Batch 4057Mfg May 2026 · Exp Apr 2028 | Net WeightWeight | Govt Analyst PunjabState lab | Jul 2026 |
| Telmisartan Tablets IP 40mg | Batch GTM94Mfg May 2025 · Exp Apr 2027 | DissolutionDissolution | DTL, Chennai-06State lab | Jun 2026 |
| Oral Rehydration Salts IP | Batch 4047Mfg Mar 2026 · Exp Feb 2028 | Net WeightWeight | SDTL, PunjabState lab | Jun 2026 |
| Oral Rehydration Salts IP | Batch 4043Mfg Mar 2026 · Exp Feb 2028 | Net WeightWeight | SDTL, PunjabState lab | Jun 2026 |
| ORAL REHYDRATION SALTS IP | Batch 4033Mfg Mar 2026 · Exp Mar 2028 | Average Net Contents per sachet found to be 20.3532gm against claim of 20.5gm per sachetOther | SDTL, PunjabState lab | Jun 2026 |
| Amitriptyline Tablets IP 25 mg | Batch GAMT4Mfg Oct 2025 · Exp Sep 2027 | ContentOther | DTL, Madurai-19State lab | Jun 2026 |
| Amlodipine Tablets IP 5mg | Batch GAB36Mfg Nov 2025 · Exp Oct 2027 | The sample received does not conform to I.P. 2022 with respect to the test for Related substances other test could not be done due to technical reason.Related substances | CDTL, MumbaiCDSCO lab | May 2026 |
| Vitamin B-Complex Tablets NFI (Prophylactic) | Batch GBC239Mfg Jun 2025 · Exp Nov 2026 | ContentOther | DTL,ChennaiState lab | Mar 2026 |
| Telmisartan Tablets IP 40mg | Batch GTM52Mfg Feb 2025 · Exp Jan 2027 | DissolutionDissolution | DTL,ChennaiState lab | Mar 2026 |
| Telmisartan Tablets IP 40mg | Batch GTM54Mfg Feb 2025 · Exp Jan 2027 | Dissolution.Dissolution | DTL, Chennai-06State lab | Feb 2026 |
| Amitriptyline Tablets IP 25mg | Batch GAMT2Mfg Jun 2025 · Exp May 2027 | ContentOther | Drugs Testing Laboratory, Madurai-19State lab | Nov 2025 |
| Amitriptyline Tablets IP 25 mg | Batch GAMT1Mfg May 2025 · Exp Apr 2027 | ContentOther | Drugs Testing Laboratory, Madurai-19State lab | Nov 2025 |
| Carbamazepine Tablets IP 200 mg | Batch GCB5Mfg Dec 2022 · Exp Nov 2024 | DISSOLUTIONDissolution | CDTL ChennaiCDSCO lab | Jul 2023 |
| Doxycycline Hydrochloride Capsules I.P. 100 mg | Batch 2002Mfg May 2021 · Exp Apr 2023 | AssayAssay | CDL KolkataCDSCO lab | Mar 2022 |
| Doxycycline Hydrochloride Capsules I.P. 100 mg | Batch 3157Mfg Mar 2020 · Exp Feb 2022 | AssayAssay | CDL KolkataCDSCO lab | Jul 2021 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.